Recombinant human erythropoietin (rhEPO) in clinical oncology: scientific and clinical aspects of anemia in cancer
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Wien [u.a.]
Springer
2002
|
| Series: | Springer Medicine
|
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | IX, 502 S. graph. Darst. |
| ISBN: | 3211836616 |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV013890385 | ||
| 003 | DE-604 | ||
| 005 | 20210623 | ||
| 007 | t | ||
| 008 | 010903s2002 d||| |||| 00||| eng d | ||
| 020 | |a 3211836616 |9 3-211-83661-6 | ||
| 035 | |a (OCoLC)50339992 | ||
| 035 | |a (DE-599)BVBBV013890385 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 050 | 0 | |a RC641 | |
| 082 | 0 | |a 616.99/4061 |2 22 | |
| 084 | |a YC 2415 |0 (DE-625)153201:12921 |2 rvk | ||
| 245 | 1 | 0 | |a Recombinant human erythropoietin (rhEPO) in clinical oncology |b scientific and clinical aspects of anemia in cancer |c M. R. Nowrousian (ed.) |
| 264 | 1 | |a Wien [u.a.] |b Springer |c 2002 | |
| 300 | |a IX, 502 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Springer Medicine | |
| 650 | 4 | |a Anemia |x Chemotherapy | |
| 650 | 4 | |a Anemia |x complications | |
| 650 | 4 | |a Anemia |x physiopathology | |
| 650 | 4 | |a Anemia |x therapy | |
| 650 | 4 | |a Cancer |x Chemotherapy |x Complications |x Chemotherapy | |
| 650 | 4 | |a Erythropoietin, Recombinant |x therapeutic use | |
| 650 | 4 | |a Neoplasms |x complications | |
| 650 | 4 | |a Recombinant erythropoietin |x Therapeutic use | |
| 650 | 0 | 7 | |a Rekombinantes Protein |0 (DE-588)4277353-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Erythropoietin |0 (DE-588)4152964-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Anämie |0 (DE-588)4126536-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Anämie |0 (DE-588)4126536-1 |D s |
| 689 | 0 | 1 | |a Erythropoietin |0 (DE-588)4152964-9 |D s |
| 689 | 0 | 2 | |a Rekombinantes Protein |0 (DE-588)4277353-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Nowrousian, Mohammad Resa |e Sonstige |0 (DE-588)107303957 |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009503711&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009503711 | ||
Record in the Search Index
| _version_ | 1804128730708180992 |
|---|---|
| adam_text | Contents
I. Biology of erythropoietin 1
C. Lacombe, P. Mayeux
II. Classification and characterization of anemia in cancer 23
M. R. Nowrousian
III. Pathophysiology of cancer related anemia 39
M. R. Nowrousian
IV. Prevalence, pathophysiology, predictive factors, and
prognostic significance of anemia in cancer chemotherapy 63
M. R. Nowrousian
V. Incidence and impact of anemia in radiation oncology 101
/. Dunst, M. Molls
VI. Relationship between anemia and tumor hypoxia 117
/. Dunst, M. Molls
VII. Tumor hypoxia and therapeutic resistance 127
P. Vaupel, M. Hockel
VIII. Impact of anemia on organ functions 147
M. R. Nowrousian
IX. Relationship between anemia, fatigue, and quality of life in
cancer patients 173
Y. Brandberg
X. Red blood cell transfusion, risks and limitations 185
F. Mercuriali, G. Inghilleri
XI. Pharmacology, pharmacokinetics and safety of recombinant
human erythropoietin (rhEPO) 203
W. Jelkmann
vui contents
XII. Recombinant human erythropoietin (rhEPO) in anemia
associated with multiple myeloma and non Hodgkin
lymphoma 223
A. Osterborg
XIII. Use of recombinant human erythropoietin in the treatment
of myelodysplastic syndromes 235
M. Cazzola
XIV. rhEPO in anemia associated with solid tumors and
chemotherapy 241 i
M. R. Nowrousian
XV. Predictive factors for response of anemia to recombinant
human erythropoietin 263
Y. Beguin
XVI. rhEPO in hematopoietic stem cell mobilization,
transplantation, and in vitro expansion 287 I
S. Klaesson
XVII. Clinical trials using rhEPO in radiation oncology 301
M. Henke
XVIII. rhEPO in pediatric oncology 313
C. Cappelli, G. Ragni, A. Clerico
XIX. rHuEPO in surgical oncology 325
F. Mercuriali, G. Inghilleri
XX. Erythropoiesis, iron metabolism and iron supplementation ]
during erythropoietin therapy 347
L. T. Goodnough
XXI. Optimal level of hemoglobin in cancer patients 369
M. R. Nowrousian
]
XXII. Protection of metabolic and exercise capacity following J
treatment with recombinant erythropoietin 391
K. Lundholm, P. Daneryd
XXIII. Effects of treatment with rhEPO on quality of life in
anemic cancer patients 405 ;
S.S.Yip, P. G. Harper 1
XXIV. Effect of rhEPO on survival in anaemic cancer patients
receiving chemotherapy 425
T. J. Littlewood
XXV. Cost effectiveness of rHuEPO in oncology 435
P. Y. Cremieux, Ellison Dial, M. Gustafson, B. Sarokhan,
M. B. Slavin
XXVI. Current status and future developments of rhEPO in
clinical oncology 447
M. R. Nowrousian
Subject Index 493
|
| any_adam_object | 1 |
| author_GND | (DE-588)107303957 |
| building | Verbundindex |
| bvnumber | BV013890385 |
| callnumber-first | R - Medicine |
| callnumber-label | RC641 |
| callnumber-raw | RC641 |
| callnumber-search | RC641 |
| callnumber-sort | RC 3641 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YC 2415 |
| ctrlnum | (OCoLC)50339992 (DE-599)BVBBV013890385 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01953nam a2200493 c 4500</leader><controlfield tag="001">BV013890385</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210623 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">010903s2002 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3211836616</subfield><subfield code="9">3-211-83661-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)50339992</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013890385</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC641</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 2415</subfield><subfield code="0">(DE-625)153201:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Recombinant human erythropoietin (rhEPO) in clinical oncology</subfield><subfield code="b">scientific and clinical aspects of anemia in cancer</subfield><subfield code="c">M. R. Nowrousian (ed.)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Wien [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IX, 502 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Springer Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anemia</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anemia</subfield><subfield code="x">complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anemia</subfield><subfield code="x">physiopathology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anemia</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Complications</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Erythropoietin, Recombinant</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recombinant erythropoietin</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rekombinantes Protein</subfield><subfield code="0">(DE-588)4277353-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Erythropoietin</subfield><subfield code="0">(DE-588)4152964-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Anämie</subfield><subfield code="0">(DE-588)4126536-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Anämie</subfield><subfield code="0">(DE-588)4126536-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Erythropoietin</subfield><subfield code="0">(DE-588)4152964-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Rekombinantes Protein</subfield><subfield code="0">(DE-588)4277353-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nowrousian, Mohammad Resa</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)107303957</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009503711&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009503711</subfield></datafield></record></collection> |
| id | DE-604.BV013890385 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:53:53Z |
| institution | BVB |
| isbn | 3211836616 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009503711 |
| oclc_num | 50339992 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | IX, 502 S. graph. Darst. |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Springer |
| record_format | marc |
| series2 | Springer Medicine |
| spelling | Recombinant human erythropoietin (rhEPO) in clinical oncology scientific and clinical aspects of anemia in cancer M. R. Nowrousian (ed.) Wien [u.a.] Springer 2002 IX, 502 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Springer Medicine Anemia Chemotherapy Anemia complications Anemia physiopathology Anemia therapy Cancer Chemotherapy Complications Chemotherapy Erythropoietin, Recombinant therapeutic use Neoplasms complications Recombinant erythropoietin Therapeutic use Rekombinantes Protein (DE-588)4277353-2 gnd rswk-swf Erythropoietin (DE-588)4152964-9 gnd rswk-swf Anämie (DE-588)4126536-1 gnd rswk-swf Anämie (DE-588)4126536-1 s Erythropoietin (DE-588)4152964-9 s Rekombinantes Protein (DE-588)4277353-2 s DE-604 Nowrousian, Mohammad Resa Sonstige (DE-588)107303957 oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009503711&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Recombinant human erythropoietin (rhEPO) in clinical oncology scientific and clinical aspects of anemia in cancer Anemia Chemotherapy Anemia complications Anemia physiopathology Anemia therapy Cancer Chemotherapy Complications Chemotherapy Erythropoietin, Recombinant therapeutic use Neoplasms complications Recombinant erythropoietin Therapeutic use Rekombinantes Protein (DE-588)4277353-2 gnd Erythropoietin (DE-588)4152964-9 gnd Anämie (DE-588)4126536-1 gnd |
| subject_GND | (DE-588)4277353-2 (DE-588)4152964-9 (DE-588)4126536-1 |
| title | Recombinant human erythropoietin (rhEPO) in clinical oncology scientific and clinical aspects of anemia in cancer |
| title_auth | Recombinant human erythropoietin (rhEPO) in clinical oncology scientific and clinical aspects of anemia in cancer |
| title_exact_search | Recombinant human erythropoietin (rhEPO) in clinical oncology scientific and clinical aspects of anemia in cancer |
| title_full | Recombinant human erythropoietin (rhEPO) in clinical oncology scientific and clinical aspects of anemia in cancer M. R. Nowrousian (ed.) |
| title_fullStr | Recombinant human erythropoietin (rhEPO) in clinical oncology scientific and clinical aspects of anemia in cancer M. R. Nowrousian (ed.) |
| title_full_unstemmed | Recombinant human erythropoietin (rhEPO) in clinical oncology scientific and clinical aspects of anemia in cancer M. R. Nowrousian (ed.) |
| title_short | Recombinant human erythropoietin (rhEPO) in clinical oncology |
| title_sort | recombinant human erythropoietin rhepo in clinical oncology scientific and clinical aspects of anemia in cancer |
| title_sub | scientific and clinical aspects of anemia in cancer |
| topic | Anemia Chemotherapy Anemia complications Anemia physiopathology Anemia therapy Cancer Chemotherapy Complications Chemotherapy Erythropoietin, Recombinant therapeutic use Neoplasms complications Recombinant erythropoietin Therapeutic use Rekombinantes Protein (DE-588)4277353-2 gnd Erythropoietin (DE-588)4152964-9 gnd Anämie (DE-588)4126536-1 gnd |
| topic_facet | Anemia Chemotherapy Anemia complications Anemia physiopathology Anemia therapy Cancer Chemotherapy Complications Chemotherapy Erythropoietin, Recombinant therapeutic use Neoplasms complications Recombinant erythropoietin Therapeutic use Rekombinantes Protein Erythropoietin Anämie |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009503711&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT nowrousianmohammadresa recombinanthumanerythropoietinrhepoinclinicaloncologyscientificandclinicalaspectsofanemiaincancer |